Search results
Lilly Alzheimer’s drug gets unanimous backing of FDA panel
BioPharma Dive via Yahoo Finance· 13 hours agoShould the agency grant approval, donanemab would be the third Alzheimer’s therapy of its kind...
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
CNBC· 9 hours agoEli Lilly & Co.'s shares climbed in early US trading after its experimental drug for Alzheimer's...
Alzheimer’s drug that can slow disease gets backing from FDA advisers
Chicago Tribune· 7 hours agoA closely watched Alzheimer’s drug from Eli Lilly won the backing of federal health advisers on...
Novel radiotracer produces high quality images of 'Alzheimer's disease of the heart'
Medical Xpress· 10 hours agoAs the first amyloid-specific and pan-amyloid binding radiotracer designed for planar and SPECT/CT imaging, 99mTc-p5+14 could play an important role in ...
Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s Drug
New York Times· 8 hours agoThe modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously. Gina Kolata and Pam Belluck have reported for years on progress and disappointments ...
FDA Panelists Unanimously Back Eli Lilly's Biogen-Rivaling Alzheimer's Drug
Investor's Business Daily· 8 hours agoAmyloid beta is a hallmark of Alzheimer's disease. But removing it can lead to brain swelling known...
How Can Biomarkers Help Diagnose Alzheimer's?
Healthline· 6 days agoAlzheimer’s disease is a neurodegenerative condition that can cause difficulties with thinking and memory and physical decline. Biomarkers can help...
Lilly's Alzheimer's drug faces delayed reckoning
Axios· 17 hours agoWhy it matters: Their conclusions could influence how the FDA treats future drugs that target proteins in the brain known as amyloid plaques that are...
FDA advisers endorse Eli Lilly’s early-stage Alzheimer’s drug donanemab - East Idaho News
EastIdahoNews.com· 2 hours agoDonanemab works by helping the body remove amyloid plaque buildups in the brain that are a hallmark...
Expert Panel Recommends FDA Approve Alzheimer's Drug
newser· 5 hours agoThe FDA approved a similar infused drug, Leqembi, from Japanese drugmaker Eisai last year. The slowdown seen with both drugs amounts to several months,...